Characteristics of prostate cancer in men less than 50-year-old;Spécificités du cancer de la prostate avant l'âge de 50 ans

Progres en Urologie

Volumn 19, Issue 11, 2009, Pages 803-809

  Peyromaure, M ^a   Valeri A ^a   Rebillard, X ^a   Beuzeboc, P ^a   Richaud, P ^a   Soulie M ^a   Salomon, L ^a  

^a Institut Cochin   (France)

Author keywords

Age; Prostate cancer; Radical prostatectomy; Surveillance; Young

Indexed keywords

AGE; HUMAN; INCIDENCE; MALE; MIDDLE AGED; PROSTATE TUMOR; SHORT SURVEY;

AGE FACTORS; HUMANS; INCIDENCE; MALE; MIDDLE AGED; PROSTATIC NEOPLASMS;

EID: 71649115372     PISSN: 11667087     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.purol.2009.04.010     Document Type: Short Survey

References (38)

1. Smith C., Bauer J., Connelly R., Seay T., Kane C., Foley J., et al. Prostate cancer in men age 50 years or younger: a review of the Department of Defense Center for Prostate Disease Research multicenter prostate cancer database. J Urol 164 (2000) 1964-1967
2. Riopel M., Polascik T., Partin A., et al. Radical prostatectomy in men less than 50 years old. Urol Oncol 1 (1995) 80-83
3. Khan M.A., Han M., Partin A.W., Epstein J.I., and Walsh P.C. Long-term cancer control of radical prostatectomy in men younger than 50 years of age: update 2003. Urology 62 (2003) 86-92
4. Siddiqui S.A., Sengupta S., Slezak J.M., et al. Impact of patient age at treatment on outcome following radical retropubis prostatectomy for prostate cancer. J Urol 175 (2006) 952-957
5. Magheli A., Rais-Bahrami S., Humphreys E.B., et al. Impact of patient age on biochemical recurrence rates following radical prostatectomy. J Urol 178 (2007) 1933-1938
6. Cussenot O., Valeri A., and Fournier G. Formes familiales des cancers de la prostate. Concours Med 127 (2005) 1257-1262
7. Valeri A., Azzouzi R., Drelon E., Delannoy A., Mangin P., Fournier G., et al. Early-onset hereditary prostate cancer is not associated with specific clinical and biological features. Prostate 45 (2000) 66-71
8. Brawley O.W., Knopf K., and Merrill R. The epidemiology of prostate cancer part I: descriptive epidemiology. Semin Urol Oncol 16 (1998) 187-192
9. Roupret M., Fromont G., Bitker M.O., Gattegno B., Vallancien G., and Cussenot O. Outcome after radical prostatectomy in young men with or without a family history of prostate cancer. Urology 67 (2006) 1028-1032
10. Cochran J.S., and Kadesky M.C. A private practice experience with adenocarcinoma of the prostate in men less than 50 years old. J Urol 125 (1981) 220-221
11. Huben R., Natarajan N., Pontes E., Mettlin C., Smart C.R., and Murphy G.P. Carcinoma of prostate in men less than fifty years old. Data from American College of Surgeons' National Survey. Urology 20 (1982) 585-588
12. Varkarakis J., Pinggera G.M., Sebe P., Berger A., Bartsch G., and Horninger W. Radical retropubic prostatectomy in men younger than 45 years diagnosed during early prostate cancer detection program. Urology 63 (2004) 337-341
13. Catalona W.J., Antenor J.A., Roehl K.A., and Moul J.W. Screening for prostate cancer in high risk populations. J Urol 168 (2002) 1980-1983
14. Loeb S., Nadler R.B., Roehl K.A., Antenor J.A., and Catalona W.J. Risk of prostate cancer for young men with a prostate specific antigen less than their age specific median. J Urol 177 (2007) 1745-1748
15. Loeb S., Roehl K.A., Antenor J.A., Catalona W.J., Suarez B.K., and Nadler R.B. Baseline prostate-specific antigen compared with median prostate-specific antigen for age group as predictor of prostate cancer risk in men younger than 60 years old. Urology 67 (2006) 316-320
16. Valeri A., Cormier L., Moineau M.P., Cancel-Tassin G., Azzouzi R., Baschet F., et al. Targeted screening of prostate cancer in high risk families: early onset is a significant risk factor of the disease in first degree relatives. J Urol 168 (2002) 483-487
17. Valeri A., Moineau M.P., Azzouzi A.R., Cormier L., Baschet F., Cussenot I., et al. Étude française sur le dépistage du cancer de la prostate dans les familles à risque : bilan à 5 ans dans le groupe 40-49 ans. Prog Urol 18 (2008) 736 [Abstract]
18. Yin M., Bastacky S., Chandran U., Becich M.J., and Dhir R. Prevalence of incidental prostate cancer in the general population: a study of healthy organ donors. J Urol 179 (2008) 892-895
19. Sánchez-Chapado M., Olmedilla G., Cabeza M., Donat E., and Ruiz A. Prevalence of prostate cancer and prostatic intraepithelial neoplasia in Caucasian Mediterranean males: an autopsy study. Prostate 54 (2003) 238-247
20. Carter HB, Allaf ME, Partin AW. Diagnosis and staging of prostate cancer. In: W. AJ, Kavoussi LR, Novick AC, Partin AW, Peters CA, editors. Campbell-Walsh Urology. Philadelphia: Saunders Elsevier; 2007. p. 2912-31.
21. Varkarakis J., Pinggera G.M., Sebe P., et al. Radical prostatectomy in men younger than 45 years diagnosed during early prostate cancer detection. Urology 63 (2004) 337-341
22. Twiss C., Slova D., and Lepor H. Outcomes for men younger than 50 years undergoing radical prostatectomy. Urology 66 (2005) 141-146
23. Descazeaud A., Debré B., and Flam T.A. Age difference between patient and partner is a predictive factor of potency rate following radical prostatectomy. J Urol 176 (2006) 2594-2598
24. Kupelian P.A., Elshaikh M., Reddy C.A., et al. Comparison of the efficacy of local therapies for localized prostate cancer in the prostate-specific antigen era: a large single-institution experience with radical prostatectomy and external-beam radiotherapy. J Clin Oncol 20 (2002) 3376-3385
25. Nguyen T.D., Poortmans P.M., Van den Hulst M., et al. The curative role of radiotherapy in adenocarcinoma of the prostate in patients under 55 years of age: a rare cancer network retrospective study. Radiother Oncol 77 (2005) 286-289
26. Rosser C.J., Chichakli R., Levy L.B., et al. Biochemical disease-free survival in men younger than 60 years with prostate cancer treated with external beam radiation. J Urol 168 (2002) 536-541
27. Park S.S., McGrath S., Ghilezan M., et al. Impact of young age on clinical outcome in prostate cancer treated with high-dose RT in the modern era. Int J Radiat Oncol Biol Phys 72 Suppl. (2008) [Abstract]
28. Brenner D.J., Curtis R.E., Hall E.J., et al. Second malignancies in prostate carcinoma patients after radiotherapy compared with surgery. Cancer 88 (2000) 398-406
29. Nieder A.M., Porter M.P., and Soloway M.S. Radiation therapy for prostate cancer increases subsequent risk of bladder and rectal cancer: a population based cohort study. J Urol 180 (2008) 2005-2009
30. Sharkey J., Cantor A., Solc Z., et al. 103Pd brachytherapy versus radical prostatectomy in patients with clinically-localized prostate cancer: a 12-year experience from a single group practice. Brachytherapy 4 (2005) 34-44
31. Merrick G.S., Butler W.M., Wallner K.E., et al. Permanent interstitial brachytherapy in younger patients with clinically organ-confined prostate cancer. Urology 64 (2004) 754-759
32. Shapiro E.Y., Morgenstern C., Napolitano B., et al. Assessment of long term outcomes from permanent prostate brachytherapy: does patient age impact outcome?. Int J Radiat Oncol Biol Phys 72 Suppl. (2008) [Abstract]
33. Cesaretti J.A., Kao J., Stone N.N., et al. Effect of low dose-rate prostate brachytherapy on the sexual health of men with optimal sexual function before treatment: analysis at > or = 7 years of follow-up. BJU Int 100 (2007) 362-367
34. Klotz L. Active surveillance with selective delayed intervention: using natural history to guide treatment in good risk prostate cancer. J Urol 172 (2004) S48-50
35. Carter H.B., Kettermann A., Warlick C., et al. Expectant management of prostate cancer with curative intent: an update of the Johns Hopkins experience. J Urol 178 (2007) 2359-2364
36. Roemeling S., Roobol M.J., De Vries S.H., et al. Active surveillance for prostate cancer detected in three subsequent rounds of a screening trial: characteristics. PSA doubling time and outcomes. Eur Urol 51 (2007) 1244-1250
37. Dall'era M.A., Konety B.R., Cowan J.E., et al. Active surveillance for the management of prostate cancer in a contemporary cohort. Cancer 112 (2008) 1650-1659
38. Bill-Axelson A., Holmberg L., Filen F., et al. Radical prostatectomy versus watchful waiting in localized prostate cancer: the Scandinavian prostate cancergroup-4 randomized trial. J Natl Cancer Inst 100 (2008) 1144-1154